| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
| 02/15/2006 | CN1733799A Gene mutated archaerhodopsin 4 protein and its preparation method and uses |
| 02/15/2006 | CN1242065C Pig breeding and respiratory syndrome recombinant adenovirus and vaccine |
| 02/15/2006 | CN1242064C Transgene plant breeding method using Rice flavamonocell hrf 1 gene |
| 02/15/2006 | CN1242063C PGO of RNA1 carrier possessing labelling of green fluorescence protein and screening tag of resistance |
| 02/15/2006 | CN1242062C Method for producing a peptide with a pi above 8 or below 5 |
| 02/15/2006 | CN1242061C Short finger gene |
| 02/15/2006 | CN1242047C Method and device for creating micro-arrays |
| 02/15/2006 | CN1241946C Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 02/15/2006 | CN1241944C Antibody againts 'alpha'-chain of human interleukin 5 receptor |
| 02/15/2006 | CN1241941C Protein for promoting nerve differentiation and resisting cell death, and its coding gene |
| 02/15/2006 | CN1241940C Novel collagen-like protein CLAC, Precursor thereof and genes encoding the same |
| 02/15/2006 | CN1241939C Gene BjCET4 of Indian mustard cation output transporting proteins and its protein |
| 02/15/2006 | CN1241646C Improvement in or relating to endometrial function |
| 02/15/2006 | CN1241640C Genetically engineered pylorospirobacillus vaccine |
| 02/15/2006 | CN1241638C IFNAR2/I FN complex |
| 02/15/2006 | CN1241637C Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor |
| 02/15/2006 | CN1241549C Amphoteric liposomes and the use thereof |
| 02/14/2006 | USRE38981 DNA sequence coding for protein C |
| 02/14/2006 | US6998521 Cotton cultivar 01W34 |
| 02/14/2006 | US6998520 Cotton cultivar 02T57R |
| 02/14/2006 | US6998517 Promoter linked to nucleotide, introduced to the plant using Agrobacterium; gene expression inhibition |
| 02/14/2006 | US6998516 Agrobacterium-mediated transformation of sunflower cotyledon cells, induction of transgenic shoots, and regeneration of fertile transgenic sunflower plants |
| 02/14/2006 | US6998515 Use of a nucleic acid encoding a hypersensitive response elicitor polypeptide to enhance growth in plants |
| 02/14/2006 | US6998514 Murine expression of a human IgA lambda locus |
| 02/14/2006 | US6998478 The promoter controls specific gene expression at the transcriptional level in cotton fibers so may be used in improving cotton fibers to create new cotton varieties with high fiber quality and yield by gene manipulation. |
| 02/14/2006 | US6998477 the fragment has promotes expression of a structural gene located at a downstream site; a plant in which expression of a desired structural gene is promoted |
| 02/14/2006 | US6998476 Nucleic acids encoding antagonists of interleukin-15 |
| 02/14/2006 | US6998475 Variants of traf2 which act as an inhibitor of tnf-alpha (tnfα) signaling pathway |
| 02/14/2006 | US6998474 used for prevention and/or treatment of pathologies, dysfunctions, disorders or conditions affecting the nervous system |
| 02/14/2006 | US6998473 isolated polynucleotide molecules which encode the isoforms ; methods of screening compounds for vitamin D receptor (VDR) agonists and/or antagonists |
| 02/14/2006 | US6998472 Obesity gene |
| 02/14/2006 | US6998471 Plant extract; hybrid nucleic acids; genetic engineering; polymerase chain reactions cycles |
| 02/14/2006 | US6998469 for treating thrombosis and other vascular diseases |
| 02/14/2006 | US6998383 Inhibitors of receptor activator of NF-κB and uses thereof |
| 02/14/2006 | US6998274 Composite arrays utilizing microspheres |
| 02/14/2006 | US6998268 Gene preparations |
| 02/14/2006 | US6998267 transformed plant cell is obtained by introducing to a plant cell a gene encoding a glycosyltransferase enzyme and a gene encoding an exogenous glycoprotein, cultivating the obtained transformed plant cell |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | US6998261 Functional gene array in yeast |
| 02/14/2006 | US6998260 DNA expression construct comprising, in 5' to 3' order: a promoter operationally linked to a secretion signal sequence, the secretion signal sequence operationally-linked to a DNA sequence encoding a proteolytic tryptase having active site mutation |
| 02/14/2006 | US6998258 L-pantolactone-hydrolase and a method for producing D-pantolactone |
| 02/14/2006 | US6998257 Recombinant minimal catalytic vanadium haloperoxidases and their uses |
| 02/14/2006 | US6998256 Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate |
| 02/14/2006 | US6998255 polynucleotides and polypeptides relating to a G-protein coupled receptor, IGS4, which exists in two polymorphic forms, IGS4A and IGS4B; use as therapeutic target and for treatment of PNS, psychiatric and CNS disorders, including schizophrenia |
| 02/14/2006 | US6998252 vaccinia virus modified by insertion of chimeric gene containing vaccinia regulatory sequences or DNA sequences functionally equivalent thereto flanking DNA sequences which to nature are not contiguous with flanking vaccinia regulatory dna sequence |
| 02/14/2006 | US6998245 Serine protease BSSP5 |
| 02/14/2006 | US6998244 contacting a cell transformed or transfected with an expression vector capable of expressing 5-HT4 receptor with a compound in presence of a ligand, monitoring CAMP formation in the cell, a change indicates compund as an antagonist or agonist |
| 02/14/2006 | US6998242 Method of diagnosing metabolic bone diseases |
| 02/14/2006 | US6998238 Method for determining MIF content |
| 02/14/2006 | US6998236 Methods for detecting interaction between a test moiety and a plurality of target moieties |
| 02/14/2006 | US6998231 Coding or classification of prion sample; obtain sample, monitor physical properties of sample, compare to control |
| 02/14/2006 | US6998229 Used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample |
| 02/14/2006 | US6998122 which retain wild-type biological activity and extend half-lives in human blood; resistant to serpin activation; for treatment of vascular occlusive disorders, hypercoagulable states, and thrombotic disorders |
| 02/14/2006 | US6998120 which induces the protection mechanisms of plants by releasing cutin monomer (such as 9-octadecenamide, which hydrolyzes cuticles of fruit), generating hydrogen peroxide and expressing pathogenic related genes |
| 02/14/2006 | US6998118 Transducing neuron with gene; Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis |
| 02/14/2006 | US6998117 Cancer treatment with retroviral vectors comprising wild-type p53 |
| 02/14/2006 | US6998115 Biodegradable and biocompatible and may be used in a variety of drug delivery systems; suited for the delivery of polynucleotides |
| 02/14/2006 | US6998108 Antibodies to p30 polypeptides and methods making and using same |
| 02/14/2006 | US6998042 Solid compositions for selective adsorption from complex mixtures |
| 02/14/2006 | CA2384170C Cgmp-visualizing probe and method of detecting and quantifying cgmp by using the same |
| 02/14/2006 | CA2383391C Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 02/14/2006 | CA2336597C Hepatitis c inhibitor peptides |
| 02/14/2006 | CA2307060C Nucleic acids having promoter activity and transgenic plants containing the same |
| 02/14/2006 | CA2306762C Synthesis of polynucleotides having random sequences |
| 02/14/2006 | CA2269072C Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/14/2006 | CA1341496C Production of thrombin inhibitors |
| 02/09/2006 | WO2006015389A2 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 02/09/2006 | WO2006015370A2 Site specific system for generating diversity protein sequences |
| 02/09/2006 | WO2006015365A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 02/09/2006 | WO2006015045A2 Methods and compositions for modulating flowering and maturity in plants |
| 02/09/2006 | WO2006014752A2 Use of apoptosis-specific eif-5a sirnas and antisense polynucleotides to inhibit/suppress an inflammatory response |
| 02/09/2006 | WO2006014726A2 Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| 02/09/2006 | WO2006014683A2 Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| 02/09/2006 | WO2006014642A1 Method of producing autologous embryonic stem cells |
| 02/09/2006 | WO2006014578A2 Method and composition for longevity assurance |
| 02/09/2006 | WO2006014540A2 Plant n-acylethanolamine binding proteins |
| 02/09/2006 | WO2006014271A2 Generation of plants with altered oil content |
| 02/09/2006 | WO2006014234A2 Novel recombinant poxvirus composition and uses thereof |
| 02/09/2006 | WO2006014022A1 Instrument for detecting bacterium, method of detecting bacterium and kit for detecting bacterium |
| 02/09/2006 | WO2006013926A1 Reaction vessel, reaction vessel liquid introducing device, liquid introducing and reaction measuring device, and liquid introducing device |
| 02/09/2006 | WO2006013904A1 Medicinal composition containing meltrin antagonist |
| 02/09/2006 | WO2006013859A1 Yeast promoter |
| 02/09/2006 | WO2006013807A1 Arabinogalactan protein having activity of improving tolerance to heat or moisture stress |
| 02/09/2006 | WO2006013733A1 Method for treating synovial sarcoma using sirna for fzd10 |
| 02/09/2006 | WO2006013572A2 Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same |
| 02/09/2006 | WO2006013472A2 Novel anti-igf-ir antibodies and uses thereof |
| 02/09/2006 | WO2006013367A2 Chimeric heamaglutinin proteins and uses thereof |
| 02/09/2006 | WO2006013281A1 Use of nucleotide sequences to obtain seeds with increased germinating capacity under hypoxic condition |
| 02/09/2006 | WO2006013226A1 Transgenic tomato plants with acquired resistance to pseudomonas syringae pv. tomato |
| 02/09/2006 | WO2006013103A2 Inducible gene expression |
| 02/09/2006 | WO2006013010A2 Preparation of organisms with faster growth and/or higher yield |
| 02/09/2006 | WO2006013003A1 Use of products derived from selenoprotein t, in its application related to calcium homeostasis |
| 02/09/2006 | WO2006012985A2 Method for production of transgenic plants with increased pathogenic resistance by altering the content and/or activity of actin-depolymerising factors |
| 02/09/2006 | WO2006012906A1 Rna virus-derived plant expression system |
| 02/09/2006 | WO2006012902A2 Creation of diversity in polypeptides |
| 02/09/2006 | WO2006012896A1 Cellular transfer of nucleic acid materials |
| 02/09/2006 | WO2005123911A3 Proteases |
| 02/09/2006 | WO2005118864A3 Antibodies and related molecules that bind to psca proteins |
| 02/09/2006 | WO2005118814A9 Metabolically engineered cells for the production of polyunsaturated fatty acids |